Clinical trialNCT00661362CompletedPhase 3Interventional

Evaluate Efficacy and Safety of Saxagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes

SponsorAstraZenecaEnrollment570Type 2 Diabetes

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Deborah Price, MSc
AstraZeneca
Study Chair
clinicaltrials.gov ↗
Peter Ohman, MD
AstraZeneca
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

30 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China

Research Site
Hefei, Anhui, China
Research Site
Beijing, China, China
Research Site
Chongqing, China, China
Research Site
Guangzhou, Guangdong, China
Research Site
Shijiazhuang, Hebei, China
Research Site
Ha'er Bing, Hei Longjiang, China
Research Site
Wuhan, Hubei, China
Research Site
Changsha, Hunan, China
Research Site
Nanjing, Jiangsu, China
Research Site
Changchun, Jilin, China
Research Site
Dalian, Liaoning, China
Research Site
Shenyang, Liaoning, China
Research Site
Shanghai, Shanghai Municipality, China
Research Site
Chengdu, Sichuan, China
Research Site
Hangzhou, Zhejiang, China
Research Site
Tianjin, China

India

Research Site
Hyderabad, Andhra Pradesh, India
Research Site
Bangalore, Karnataka, India
Research Site
Mangalore, Karnataka, India
Research Site
Nagpur, Maharashtra, India
Research Site
Bangalore, India

South Korea

Research Site
Seongnam-si, Gyeonggi-do, South Korea
Research Site
Bucheon-si, South Korea
Research Site
Daegu, South Korea
Research Site
Goyang, South Korea
Research Site
Gwangju, South Korea
Research Site
Incheon, South Korea
Research Site
Pusan, South Korea
Research Site
Seoul, South Korea
Research Site
Uijeongbu-si, South Korea

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Jun 2008
Primary completion: 30 Sept 2009
Completion: 30 Sept 2009
Last update posted: 8 Mar 2012
Registered enrollment: 570
Registry id: NCT00661362

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.